GPT and metabolic dysfunction-associated steatotic liver disease: Contrary to our study Ijaz et al. showed in their study that raised ALT and AST were not a common finding in Type-2 diabetics having NAFLD.26 Similarly Gabriele et al. showed in their study that ALT levels are not predictable of NAFLD in Type-2 diabetics.27 The prevalence of NAFLD in Type-2 diabetes mellitus continues to be overlooked by clinicians, but there is an increased awareness about the negative health consequences of steatohepatitis.